Precautionary advice on persistent psychiatric and sexual side effects extended to dutasteride
What the MHRA said
The MHRA extended to dutasteride the precautionary advice it had issued for finasteride in April 2024, and strengthened the warnings covering psychiatric reactions and sexual dysfunction that have been reported to persist after treatment is stopped.
What it means if you are taking this
Dutasteride is used off-label for hair loss in the UK, so it is easy to assume the finasteride safety position does not apply to it. As of this update it explicitly does. If you are on dutasteride rather than finasteride, you are not outside the warning, and dutasteride has a terminal half-life of roughly five weeks against finasteride's six hours, so anything you do notice takes considerably longer to clear.
Affects what we range as Finasteride 1 mg tablets, Dutasteride 0.5 mg capsules.